4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000004
Director sold 20 shares at $490.17 ($9,803)
- Director acquired 20 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CAUSEY CHRISTOPHER · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +20 | $119.76 | $2,395 | 4,210 | D |
| 2026-03-04 | Sale : show line 2 in the form 10b5-1 | −20 | $490.17 | $9,803 | 4,190 | D |
| Open-market sales · 20 sh · avg $490.17 · $9,803 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-04 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −20 | 6,300 | D |
Loading xslF345X05/primarydocument.xml…